A breakthrough in pancreatic cancer has experts excited
Medical experts are reporting a breakthrough in pancreatic cancer treatment involving a new pill and fast-tracked regulatory reviews.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Developments in the treatment of metastatic pancreatic ductal adenocarcinoma (PDAC) have emerged, specifically regarding Zoldonrasib combinations. These combinations have demonstrated compelling antitumor activity in cases involving RAS G12D–mutant metastatic PDAC.
Coverage from STAT, WBUR, and AL.com emphasizes a sense of new hope for patients. Technical reporting from OncLive focuses on the specific genetic mutations targeted, while the European Medicines Agency (EMA) has announced it is fast-tracking the review of the medicine.
Attention now turns to the outcome of the EMA's accelerated review process to determine the availability of the treatment.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Quick answers
What specific drug is mentioned in the coverage?
The coverage mentions Zoldonrasib combinations.
Which patients may benefit from this treatment?
The treatment showed activity in those with RAS G12D–mutant metastatic PDAC.
What action is the European Medicines Agency taking?
The EMA is fast-tracking the review of the medicine for metastatic pancreatic cancer.
Coverage (5)
- New hope of more birthdays, holidays for pancreatic cancer patients: op-ed AL.com · 11h ago
- Zoldonrasib Combinations Show Compelling Antitumor Activity in RAS G12D–Mutant Metastatic PDAC OncLive · 11h ago
- EMA fast tracks review of a medicine for metastatic pancreatic cancer European Medicines Agency (EMA) · 11h ago
- The pill bringing new hope to patients with pancreatic cancer WBUR · 11h ago
- A breakthrough in pancreatic cancer has experts excited STAT · 11h ago broke it first
People, places & organizations
Topics
Related trends
Maura Gillison, Who Transformed the Treatment of Mouth and Throat Cancers, Dies at 61
The oncology community mourns Maura Gillison, a doctor whose work transformed the treatment of mouth and throat cancers.
Which ‘AI scientist’ suits your lab? A guide for the perplexed
5 news sources are covering this Technology story right now — Newsylist is tracking how fast it spreads.
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia
6 news sources are covering this Health story right now — Newsylist is tracking how fast it spreads.
Largest study yet reveals which cancers have their own microbiomes
Largest study reveals cancers with unique microbiomes
Cancer cases worldwide will soar in the coming decades, a report finds. Here’s why.
A new global report warns of a significant surge in cancer cases worldwide over the coming decades.
Pancreatic cancer breakthrough has big implications for early detection effort - San Diego Union-Tribune
Experimental cancer treatment Daraxonrasib is gaining momentum as regulators fast-track review and clinical data suggests potential advancements in patient care.